Dominika Misztela: 2024DIA-Excellent discussion on current complexity of EU legislative frameworks

Dominika Misztela, Director, Global Regulatory Affairs Science, Policy, and Intelligence – Europe at CSL, shared a post on LinkedIn:

“A real highlight of day 1 2024DIA: Excellent discussion on current complexity of EU legislative frameworks, how it might impact patient access, Europe’s future as randd generator and how to address this in a forward-looking manner

Excellent issues summary by Magda Chlebus, panel solutions include
– Building on existing interfaces, dialogue opportunities and partnerships between regulators, academia and pharmeceutical industry, to co-develop and co-design as medicines become more complex
⁃ Think ‘Team Europe’: europe is stronger together in medical advancements innovation patient access
– Joint approach as basic consistency check for new legislative approaches
– Information symmetry: Need for good data from industry and academica which can be used by regulators and translated appropriately for policy makers

and ultimately
– patient centricity: patient access to appropriate treatment should drive any decision-making”

Source: Dominika Misztela/LinkedIn